Patients should use OMNARIS Nasal Spray at regular intervals since its effectiveness depends on its regular use. In clinical trials, the onset of effect was seen within 24 to 48 hours with further symptomatic improvement observed over 1 to 2 weeks in seasonal allergic rhinitis and 5 weeks in perennial allergic rhinitis. Initial assessment of response should be made during this time frame and periodically until the patient's symptoms are stabilized. The patient should take the medication as directed and should not exceed the prescribed dosage. The patient should contact the physician if symptoms do not improve by a reasonable time or if the condition worsens.
Any communications or information you transmit to this website by electronic mail or otherwise to Chattem shall be treated as non-confidential and non-proprietary. Although we welcome your comments and feedback with respect to this website or any of our products, we are not seeking and do not review any unsolicited ideas, suggestions or materials related to the development, design, manufacture or marketing of our products or the conduct of our business. This policy is intended to avoid confusion about the ownership of new ideas and concepts and to help protect you. By sending us any proposed ideas or other such information, you agree to transfer to Chattem all of your rights and interests in such proposed intellectual property, ideas and information. You further agree that any ideas, concepts or know-how that you or individuals acting on your behalf provide to Chattem can be used, reproduced, transmitted, disclosed or published by Chattem or its affiliates without restriction or compensation.